Know Albrioza’s Role in Treating Amyotrophic Lateral Sclerosis
September 2022
Canada is the first country to approve Albrioza, a new oral med for amyotrophic lateral sclerosis (ALS).
You may commonly hear this rare, progressive, degenerative nerve disease called Lou Gehrig’s disease.
Treatment should be started early...to improve survival and help slow decline in physical function, such as worsening speech.Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote